Pilot Study Assessing the Feasibility of CD34+ Cells Mobilization and Collection After Treatment With G-CSF and Plerixafor in Patients With Fanconi Anemia for Subsequent Treatment by Gene Therapy
Phase of Trial: Phase I/II
Latest Information Update: 27 Dec 2017
At a glance
- Drugs Plerixafor (Primary) ; Filgrastim
- Indications Fanconi's anaemia
- Focus Therapeutic Use
- Acronyms EUROFANCOLEN; FancoMob
- 20 Dec 2017 Planned End Date changed from 1 May 2019 to 1 Mar 2021.
- 20 Dec 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Sep 2020.
- 11 Apr 2016 Status changed from not yet recruiting to recruiting.